Researchers reviewed how fecal microbiota transplantation, or FMT, might affect patients with colorectal cancer, liver cancer, and melanoma. This treatment involves transferring healthy bacteria into a patient's system. The review looked at how these microbes interact with the body's environment to potentially improve health outcomes.
The findings suggest that FMT may help by repairing the intestinal barrier and changing metabolism. These processes could make it easier for patients to tolerate chemotherapy and handle complications from treatment. There is also potential for FMT to improve how the body responds to immunotherapy drugs.
Because this is a systematic review of early research, there are several hurdles to overcome before it can be used widely. Challenges include finding safe donors, creating standard formulas, and ensuring long-term safety. Patients should view these findings as part of ongoing research rather than an immediate clinical change.
